Search
for
Sort by
Research 211–240 of 1000+
- Dermatologic manifestations of endocrine disorders
- Androgenic Alopecia
- Testosterone in Women: Measurement and Therapeutic Use
- Types and Treatment of Hair Loss in Men and Women
- Sulforaphane, L-Menthol, and Dexpanthenol as a Novel Active Cosmetic Ingredient Composition for Relieving Hair Loss Symptoms
- Finasteride in Androgenic Alopecia
- HAIR AND HAIR CARE: AN OVERVIEW
- EFFECTS OF HORMONAL THERAPY IN TRANSGENDERS
- Melatonin in Dermatologic Allergic Diseases and Other Skin Conditions: Current Trends and Reports
- Pharmacologic interventions in aging hair
- Addressing Androgenetic Alopecia-A Complex Disorder-with a Multilateral Treatment Strategy
- Improved Transgender Care in the ED
- An overview on 5α-reductase inhibitors
- Androgenetic Alopecia: a Review and Emerging Treatments
- Pharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine Headache
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231
- Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
- ABCD1 Gene Mutations: Mechanisms and Management of Adrenomyeloneuropathy
- A review of hormonal therapy for female pattern (androgenic) alopecia
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- Adult female acne: Clinical and therapeutic particularities (Review)
- Prediction of the Development of Depression in Patients with Autoimmune Thyroiditis and Hypothyroidism
- Drug-associated gingival disorders: a retrospective pharmacovigilance assessment using disproportionality analysis
- The Case Files
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Hyperandrogenic Disorders
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Skin manifestations of hyperandrogenism: an update
- The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease